5 entreprises

Affichage de 1–5 sur 5 entreprises

Wave Life Sciences USA, Inc.

Wave Life Sciences develops RNA medicines for severe genetic and serious disorders using its PRISM platform, with clinical candidates in obesity, liver disease, Duchenne muscular dystrophy and Huntington's disease.

1 offre ouverte

Baylor Genetics

Baylor Genetics provides genetic testing and genomic analysis, including whole genome, whole exome and RNA sequencing, as a joint venture of Baylor College of Medicine and HU Group Holdings.

1 offre ouverte

Regeneron Pharmaceuticals, Inc (USA)

Regeneron Pharmaceuticals is a US biotechnology company that discovers, develops and commercializes medicines for serious diseases using its own antibody engineering and genetics platforms.

Moderna

Moderna develops and commercialises mRNA-based medicines and vaccines, with approved products for COVID-19 and RSV and 45 development programmes across infectious disease, oncology and other areas.

1 offre ouverte

GRIFOLS, S.A.

Grifols is a global healthcare company, founded in 1909 in Barcelona, that develops plasma-derived medicines, biopharmaceuticals, transfusion medicine solutions and clinical diagnostics, employing over 23,000 people.

5 entreprises

Wave Life Sciences USA, Inc.

Baylor Genetics

Regeneron Pharmaceuticals, Inc (USA)

Moderna

GRIFOLS, S.A.

Parcourir par marché

Nous utilisons des cookies